ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,266, issued on Dec. 2, was assigned to ZHUHAI UNITED LABORATORIES Co. LTD. (Guangdong, China).
"Crystalline form of JAK inhibitor and application thereof" was invented by Weiwei Mao (Shanghai), Wenyuan Qian (Shanghai), Changqing Wei (Shanghai), Liang Fang (Guangdong, China), Liwei Mu (Guangdong, China) and Shuhui Chen (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses the crystal forms as a JAK inhibitor and their application in the preparation of drugs for the treatment of JAK1 or/and TYK2 related diseases."
The patent was filed on Feb. 22, 2021, under Application No. 17/796,613.
*For further information, incl...